Nyxoah S.A. (NYXH)
NASDAQ: NYXH · IEX Real-Time Price · USD
10.10
-0.70 (-6.48%)
May 17, 2024, 4:00 PM EDT - Market closed
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $288.34 million as of May 17, 2024. Its market cap has increased by 37.37% in one year.
Market Cap
288.34M
Enterprise Value
254.01M
1-Year Change
37.37%
Ranking
Category
Stock Price
$10.10
Market Cap Chart
Since the IPO on July 2, 2021, Nyxoah's market cap has decreased from $746.03M to $288.34M, a decrease of -61.35%. That is a compound annual growth rate of -28.14%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 289.70M | -3.18% |
May 16, 2024 | 299.20M | 1.56% |
May 15, 2024 | 294.60M | 7.21% |
May 14, 2024 | 274.80M | 8.27% |
May 13, 2024 | 253.80M | 7.54% |
May 10, 2024 | 236.00M | -3.40% |
May 9, 2024 | 244.30M | -8.30% |
May 8, 2024 | 266.40M | 2.90% |
May 7, 2024 | 258.90M | - |
May 6, 2024 | 258.90M | -7.50% |
May 3, 2024 | 279.90M | -1.69% |
May 2, 2024 | 284.70M | 4.75% |
May 1, 2024 | 271.80M | -8.36% |
Apr 30, 2024 | 296.60M | -6.55% |
Apr 29, 2024 | 317.40M | 4.24% |
Apr 26, 2024 | 304.50M | -5.93% |
Apr 25, 2024 | 323.70M | 6.34% |
Apr 24, 2024 | 304.40M | 1.30% |
Apr 23, 2024 | 300.50M | -1.12% |
Apr 22, 2024 | 303.90M | -1.40% |
Apr 19, 2024 | 308.20M | 3.35% |
Apr 18, 2024 | 298.20M | 8.91% |
Apr 17, 2024 | 273.80M | 2.66% |
Apr 16, 2024 | 266.70M | 4.51% |
Apr 15, 2024 | 255.20M | -1.24% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Black Diamond Therapeutics | 306.02M |
SOPHiA GENETICS | 303.00M |
Emergent BioSolutions | 299.21M |
Ventyx Biosciences | 295.39M |
MacroGenics | 294.66M |
Sanara MedTech | 293.69M |
Xeris Biopharma Holdings | 293.55M |
Invivyd | 293.28M |